Osaic Holdings’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$231K Sell
84,434
-2,009
-2% -$6.36K ﹤0.01% 4031
2025
Q4
$320K Buy
86,443
+5,009
+6% +$16.2K ﹤0.01% 3747
2025
Q3
$195K Buy
81,434
+3,750
+5% +$7.25K ﹤0.01% 4230
2025
Q2
$76.1K Buy
77,684
+745
+1% +$746 ﹤0.01% 4724
2025
Q1
$111K Sell
76,939
-435
-0.6% -$802 ﹤0.01% 4096
2024
Q4
$170K Buy
77,374
+744
+1% +$1.74K ﹤0.01% 3744
2024
Q3
$126K Sell
76,630
-5,950
-7% -$12K ﹤0.01% 4040
2024
Q2
$183K Buy
82,580
+3,950
+5% +$9.29K ﹤0.01% 3639
2024
Q1
$211K Buy
78,630
+6,536
+9% +$15.9K ﹤0.01% 3630
2023
Q4
$216K Buy
72,094
+727
+1% +$943 ﹤0.01% 3864
2023
Q3
$69.9K Buy
71,367
+6,736
+10% +$9.75K ﹤0.01% 4761
2023
Q2
$89.8K Buy
64,631
+4,708
+8% +$6.57K ﹤0.01% 4524
2023
Q1
$95.3K Buy
59,923
+1,299
+2% +$6.71K ﹤0.01% 4491
2022
Q4
$366K Buy
58,624
+51,801
+759% +$370K ﹤0.01% 3315
2022
Q3
$47K Buy
6,823
+3,240
+90% +$22.3K ﹤0.01% 4957
2022
Q2
$24K Buy
3,583
+62
+2% +$352 ﹤0.01% 5484
2022
Q1
$16K Sell
3,521
-62
-2% -$266 ﹤0.01% 5837
2021
Q4
$18K Buy
3,583
+119
+3% +$953 ﹤0.01% 5857
2021
Q3
$42K Hold
3,464
﹤0.01% 5229
2021
Q2
$73K Sell
3,464
-95
-3% -$2.29K ﹤0.01% 4756
2021
Q1
$99K Sell
3,559
-387
-10% -$11.4K ﹤0.01% 4352
2020
Q4
$102K Sell
3,946
-5,106
-56% -$153K ﹤0.01% 4019
2020
Q3
$404K Sell
9,052
-1,185
-12% -$46.9K ﹤0.01% 2631
2020
Q2
$526K Buy
10,237
+1,785
+21% +$74.7K ﹤0.01% 2311
2020
Q1
$270K Buy
+8,452
New +$446K ﹤0.01% 2617

Other funds holding ESPR